Cargando…
Economic evaluation of intravenous alteplase for stroke with the time of onset between 4.5 and 9 hours
BACKGROUND: A clinical trial proved the clinical effectiveness of perfusion imaging-guided intravenous thrombolysis with alteplase for patients with acute ischemic stroke (AIS) with the time of onset between 4.5 and 9 hours. This study aimed to assess the lifetime cost-effectiveness of alteplase ver...
Autores principales: | Chen, Jigang, Liang, Xin, Tong, Xin, Han, Mingyang, Ji, Linjin, Zhao, Songfeng, Hu, Zhiqiang, Liu, Aihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763196/ https://www.ncbi.nlm.nih.gov/pubmed/35074896 http://dx.doi.org/10.1136/neurintsurg-2021-018420 |
Ejemplares similares
-
Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack
por: Chen, Jigang, et al.
Publicado: (2022) -
Safety of intravenous alteplase within 4.5 hours for patients awakening with stroke symptoms
por: Urrutia, Victor C., et al.
Publicado: (2018) -
Cost-effective analysis of mechanical thrombectomy alone in the treatment of acute ischaemic stroke: a Markov modelling study
por: Han, Mingyang, et al.
Publicado: (2022) -
Cost-effectiveness of recombinant tissue-type plasminogen activator for acute ischaemic stroke with unknown time of onset: a Markov modelling analysis from the Chinese and US perspectives
por: Zhao, Songfeng, et al.
Publicado: (2022) -
Separate and combined effects of individual and neighbourhood socio-economic disadvantage on health-related lifestyle risk factors: a multilevel analysis
por: Zhu, Yinjie, et al.
Publicado: (2021)